Oman Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Oman Pharmaceuticals and Healthcare Report

Oman Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Oman Pharmaceuticals and Healthcare Report
Published May 28, 2016
78 pages — Published May 28, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

The growth of branded generic drugs will support the uptake of generic drugs Increase in healthcare budget to boost public health schemes. Rising local, as well as regional, demand for diabetes and other lifestyle treatments. ...Rising number of private pharmacies to improve exposure to OTC medicines. Generic drugs market growth driven by the cost-containment focus of the government, improving perceptions of generic medicines, as well as the free trade agreement between India and the GCC. Oman is making concerted efforts to increase its attractiveness as a medical services centre. ...Generic drugs market growth driven by the cost-containment focus of the government, improving perceptions of generic medicines, as well as the free trade agreement between India and the GCC. Oman is making concerted efforts to increase its attractiveness as a medical services centre.

...The Omani government s focus on expanding healthcare infrastructure with a number of large modern hospitals will provide a channel for overall medicines uptake. Strong demand for patented innovative drugs, driven by Oman s traditional wealth, especially among the sizeable expatriate community. ...Strong demand for patented innovative drugs, driven by Oman s traditional wealth, especially among the sizeable expatriate community. The Ministry of Health has offered financial, as well as technical support, to the private sector in the healthcare/pharmaceutical sector. The free trade agreement (FTA) with the US has improved the intellectual property regime in the country. ...Import-driven market, with a small domestic manufacturing sector.

...BMI View: Oman s evolving demographic and epidemiological profile will act as key drivers of growth within the country s pharmaceuticals and healthcare markets over the coming years. We view Oman as having considerable growth potential, supported by an expanding private sector and the government s ongoing commitment to advancing healthcare. ...

  
Source:
Document ID
1748-2070
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Oman Pharmaceuticals and Healthcare Report" May 28, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Oman-Pharmaceuticals-and-Healthcare-Report-2026-532>
  
APA:
Business Monitor International - Industry Reports. (2016). Oman Pharmaceuticals and Healthcare Report May 28, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Oman-Pharmaceuticals-and-Healthcare-Report-2026-532>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.